Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Janux Therapeutics, Inc. | 381,582 | reported | 02 Jan 2026 | tx 18+1,819,950−128,072 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Janux Therapeutics, Inc. | 96,600 | 0.00 USD | |
| 02 Jan 2026 | SALE | Janux Therapeutics, Inc. | 8,072 | 13.73 USD | |
| 02 Jan 2026 | GRANT_AWARD | Janux Therapeutics, Inc. | 338,100 | 0.00 USD | deriv |
| 07 Jan 2025 | SALE | Janux Therapeutics, Inc. | 5,000 | 60.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 81,000 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 283,500 | 0.00 USD | deriv |
| 24 Dec 2024 | SALE | Janux Therapeutics, Inc. | 25,000 | 56.19 USD | |
| 03 Dec 2024 | SALE | Janux Therapeutics, Inc. | 15,000 | 67.00 USD | |
| 25 Nov 2024 | SALE | Janux Therapeutics, Inc. | 6,719 | 52.04 USD | |
| 25 Nov 2024 | SALE | Janux Therapeutics, Inc. | 18,281 | 51.43 USD | |
| 28 Oct 2024 | SALE | Janux Therapeutics, Inc. | 13,897 | 53.22 USD | |
| 28 Oct 2024 | SALE | Janux Therapeutics, Inc. | 11,103 | 53.94 USD | |
| 27 Sept 2024 | SALE | Janux Therapeutics, Inc. | 795 | 47.84 USD | |
| 27 Sept 2024 | SALE | Janux Therapeutics, Inc. | 18,957 | 46.09 USD | |
| 27 Sept 2024 | SALE | Janux Therapeutics, Inc. | 5,248 | 46.86 USD | |
| 02 Jan 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 356,500 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | Janux Therapeutics, Inc. | 310,000 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | Janux Therapeutics, Inc. | 354,250 | 0.00 USD | deriv |